Articles from Provectus Algae
Provectus Algae (Provectus) announced today that it has raised US$10.1M in Series A financing and an additional US$2.5M in grant funding from the Australian government. The round was led by At One Ventures and included Methane Mitigation, Mort & Co, and existing shareholders, such as Hitachi Ventures, among others. Tom Chi, Founding Partner of At One Ventures, will also join the company’s Board of Directors.
By Provectus Algae · Via Business Wire · July 22, 2025

Provectus Algae (Provectus) has announced its entry into livestock methane reduction with its first 30,000 L demonstration plant commissioned in October to scale up Asparagopsis feed additives. This move signals a maturation of Provectus Algae’s operations as the company moves its lead product for the animal feed sector from pilot to large-scale production.
By Provectus Algae · Via Business Wire · November 2, 2023

Provectus Algae (Provectus) has announced that Steven F. Schnittger has joined the company as a cosmetics industry advisor. Schnittger is the former Vice-President of Global Fermentation and Microbiology R&D at The Estée Lauder Companies Inc., spending over 37 years there.
By Provectus Algae · Via Business Wire · March 21, 2023

Provectus Algae (Provectus) has secured an undisclosed strategic investment from CJ BIO, a division of South Korea-based food & bio company CJ CheilJedang.
By Provectus Algae · Via Business Wire · March 1, 2023

Provectus Algae (Provectus), an Australia-based biotechnology company specializing in photosynthetic biomanufacturing of specialty ingredients for a wide array of industries and applications, announced today that it has appointed biotech stalwart Guillaume Barbier, PhD as its Vice President of Research and Development. Barbier has more than 15 years of experience in the sector with a proven track record of building and leading successful teams and programs.
By Provectus Algae · Via Business Wire · October 26, 2022

Provectus Algae (Provectus), an Australian synthetic biology company specializing in microalgal biomanufacturing technologies for the production of specialty ingredients for a wide array of industries and applications, announced today the appointment of Dr Claudia Vickers as Chief Scientific Officer. This strategic move ushers in the next stage of organizational growth for Provectus following the completion of an $11.4 million pre-series A funding round led by Hitachi Ventures at the end of last year.
By Provectus Algae · Via Business Wire · February 22, 2022

Provectus Algae (Provectus), an Australian synthetic biology company specializing in biomanufacturing to produce specialty ingredients for a wide array of industries and applications, has secured $11.4 million in a pre-series A funding round co-led by Hitachi Ventures, the corporate venture capital arm of Hitachi and Vectr Ventures of Hong Kong. The round was further supported by Possible Ventures, Acequia Capital, existing shareholders and additional private investors.
By Provectus Algae · Via Business Wire · December 14, 2021

Provectus Algae (Provectus), an Australian biotechnology platform company specialising in the biomanufacturing of high-value compounds for a wide array of industries using microalgae, announced they will be expanding into an additional large-scale manufacturing facility.
By Provectus Algae · Via Business Wire · August 25, 2021

Provectus Algae (Provectus), an Australian biotechnology company specialising in the optimisation of algae to produce high-value compounds for use in a wide array of industries and applications, today appointed Mark Livings, co-founder and CEO of Lyre’s Non-Alcoholic Spirits and BrandLink Group, to its Advisory Board. He brings to the role a proven track record of introducing innovative products to market and rapid commercialization in the food and beverage sector.
By Provectus Algae · Via Business Wire · June 9, 2021